Andere Sprachen Getein Biotech, Inc

Aktien

A2N32D

CNE100002RR9

603387

Schlusskurs Shanghai S.E. Andere Börsenplätze 00:00:00 10.05.2024			% 5 Tage	% 1. Jan.
9,71 ^CNY	-2,22 %		+3,41 %	-11,73 %

29.04.	Getein Biotech, Inc berichtet über die Ergebnisse für das erste Quartal bis zum 31. März 2024	CI
29.04.	Getein Biotech, Inc berichtet über die Ergebnisse für das am 31. Dezember 2023 beendete Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Getein Biotech, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024	29.04.
Getein Biotech, Inc Reports Earnings Results for the Full Year Ended December 31, 2023	29.04.
Getein Biotech, Inc Reports Earnings Results for the Nine Months Ended September 30, 2023	27.10.23
Getein Biotech, Inc Reports Earnings Results for the Half Year Ended June 30, 2023	28.08.23
Getein Biotech, Inc Reports Earnings Results for the First Quarter Ended March 31, 2023	26.04.23
Getein Biotech, Inc Reports Earnings Results for the Full Year Ended December 31, 2022	30.03.23
Meihua International Unit, Getein Biotech to Develop COVID-19 Antigen Test Kits, Other In Vitro Diagnostic Products	11.01.23
Meihua International Medical Technologies Co., Ltd. Enters into Strategic Partnership with Getein Biotech Inc. to Jointly Produce and Sell Covid-19 Antigen Test Kits and IVDs	11.01.23
Getein Biotech Gets Regulatory Approval for COVID-19 Kit; Shares Up 9%	12.12.22
Getein Biotech, Inc Reports Earnings Results for the Nine Months Ended September 30, 2022	26.10.22
Yestar Healthcare, Getein Biotech End Investment Talks	24.08.22
Getein Biotech, Inc Reports Earnings Results for the Half Year Ended June 30, 2022	23.08.22
Yestar Healthcare Holdings Company Limited cancelled the transaction announced on April 8, 2022	23.08.22
Getein Biotech, Inc Reports Earnings Results for the First Quarter Ended March 31, 2022	27.04.22
Yestar Healthcare Holdings Company Limited announced that it expects to receive funding from Getein Biotech, Inc	08.04.22
Getein Biotech, Inc Reports Earnings Results for the Full Year Ended December 31, 2021	11.03.22
Sichuan Getein Biotechnology Co., Ltd. announced that it expects to receive CNY 30 million in funding from Getein Biotech, Inc	24.02.22
Getein Biotech, Inc Reports Earnings Results for the Nine Months Ended September 30, 2021	27.10.21
Getein Biotech, Inc Reports Earnings Results for the Half Year Ended June 30, 2021	17.08.21
Tranche Update on Getein Biotech, Inc's Equity Buyback Plan announced on December 31, 2020.	30.06.21

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Getein Biotech, Inc

Aktien

A2N32D

CNE100002RR9

603387

Andere Sprachen

Filter